Rigel Pharmaceuticals
RIGL
RIGL
113 hedge funds and large institutions have $272M invested in Rigel Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 35 increasing their positions, 30 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
8% more call options, than puts
Call options by funds: $193K | Put options by funds: $179K
Holders
113
Holding in Top 10
2
Calls
$193K
Puts
$179K
Top Buyers
| 1 | +$3.57M | |
| 2 | +$1.85M | |
| 3 | +$1.67M | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$1.29M |
| 5 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
+$839K |
Top Sellers
| 1 | -$1.48M | |
| 2 | -$1.37M | |
| 3 | -$1.02M | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$960K |
| 5 |
BC
Broadfin Capital
New York
|
-$912K |